--- title: Sterile Fill-Finish & Aseptic Manufacturing CDMOs in China path: /services/sterile-fill-finish/china companies_count: 11 --- # Sterile Fill-Finish & Aseptic Manufacturing CDMOs in China 11 published CDMOs match Sterile Fill-Finish & Aseptic Manufacturing in China. Locations in this set include China, United States, Singapore, United Kingdom, France, and Japan. Capabilities that show up most often in this set: Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), Peptide, and AAV / Viral Vector Platform. ## Matching companies - [Boston Institute of Biotechnology, LLC](/companies/bostonbib) - Full-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L. - [Carbogen Amcis](/companies/carbogen-amcis) - Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [JYMed Peptide](/companies/jymedtech) - Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Piramal Pharma Solutions](/companies/piramalpharmasolutions) - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management. - [Porton Advanced](/companies/porton-advanced) - End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. - [Stevanato Group](/companies/stevanatogroup) - Leading global provider of integrated drug containment, drug delivery, and diagnostic solutions with 75+ years' experience in glass primary packaging, contract manufacturing, and analytical services across development, clinical, and commercial stages. - [Unither Pharmaceuticals](/companies/unither-pharma) - Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites. - [Vetter Pharma](/companies/vetter-pharma) - Independent CDMO specialist in aseptic fill-finish, drug product development, analytical services, and combination product assembly with 76 years of experience and 7,300+ employees globally. - [WuXi XDC](/companies/wuxi-xdc) - WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.